Global Cannabis Testing Market is valued at US$ 1402.3 Million in 2022 and it is expected to reach US$ 3061.5 Million by 2029 with a CAGR of 11.8% over the forecast period
Global Cannabis Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029- Increasing legalization of cannabis, growing number of cannabis-based clinical trials and technological advancements are major factors anticipated to drive the growth of the Global Cannabis Testing Market within the forecast period.
Cannabis testing refers to the process of analyzing cannabis products for their potency, purity, and safety. The testing is typically performed by accredited laboratories using specialized equipment and techniques to ensure that cannabis products are safe for consumption. cannabis testing can include a range of different analyses, such as testing for THC and CBD levels, detecting the presence of pesticides, heavy metals, and other contaminants, and checking for the presence of bacteria or other microorganisms.
The goal of cannabis testing is to ensure that cannabis products are safe and accurately labeled, so that consumers can make informed decisions about the products they choose to use. cannabis testing has become increasingly important as the legalization of cannabis has spread across the globe. Many jurisdictions now require cannabis products to undergo testing before they can be sold to consumers, and regulatory bodies have established strict guidelines for testing protocols and acceptable levels of contaminants.
Cannabis testing can be conducted using a variety of analytical techniques, including chromatography, mass spectrometry, and immunoassays. Testing is typically performed by certified laboratories and is often required by regulatory agencies to ensure compliance with safety and quality standards.
The end-users for the global cannabis testing market include cannabis cultivators, manufacturers, and distributors. These entities rely on cannabis testing services to ensure the quality, safety, and compliance of their products. Additionally, regulatory bodies and government agencies are also important end-users, as they mandate testing requirements to protect public health and ensure regulatory compliance in the cannabis industry.
The Covid-19 has shown significant impact on the global cannabis testing market. The shutdown of non-essential labs and testing facilities in response to lockdowns did have a temporary negative impact on sales of cannabis testing equipment and services. However, as the pandemic has continued, there have been positive developments.
For instance; as per the news published on August 6th, 2020; Eybna and CannaSoul collaborated to develop a cannabis terpene formulation for treating Covid-19. This has led to increased interest and research in the potential therapeutic benefits of cannabis, which could create new opportunities for the cannabis testing industry as more compounds are isolated and tested.
Additionally, as the cannabis industry has been deemed essential in many jurisdictions, some testing facilities have been able to remain open and have even seen increased demand for their services as consumers seek out high-quality and safe cannabis products.
The global cannabis testing market is segmented on the basis of product & software, test type test type, end-users and region & country level. On the basis of test type, the market is segmented into, heavy metal testing, potency testing, terpene profiling, residual solvent analysis, microbial analysis, pesticide screening and other services. On the basis of product & software, the global cannabis testing market is segmented into analytical instruments, spectroscopy instruments, consumables and software, services. On the basis of end-users, the global cannabis testing market is segmented into, cultivators/producers, drug manufacturers & dispensaries, cannabis testing laboratories AND research institutions.
The regions covered in global cannabis testing market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global cannabis testing market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
some of the key players for global cannabis testing market are -
One of the major factors driving the global cannabis testing market is the increasing legalization of cannabis. In recent years, there has been a growing trend towards the legalization of cannabis, both for medical and recreational use, in various countries worldwide. As more countries legalize cannabis, the demand for cannabis testing services is increasing, as there is a need to ensure that the products are safe and comply with regulatory standards.
For instance; in 2018, Farm Bill legalized the cultivation, processing, and sale of hemp and hemp-derived products in the United States, which has opened up a new market for hemp-based products such as CBD oil. Similarly, many countries in Europe and Asia have been legalizing medical cannabis to address the increasing patient population suffering from various medical conditions that can be treated with cannabis-based product
In addition, the growing number of cannabis-based clinical trials are also supplementing the market growth. There has been a growing interest in conducting clinical trials to explore the potential therapeutic benefits of cannabis-based products. These clinical trials are focused on evaluating the safety and efficacy of cannabis-based products for treating various medical conditions such as chronic pain, epilepsy, multiple sclerosis, and nausea caused by chemotherapy, among others.
The results of these clinical trials can provide valuable insights into the medical uses of cannabis and help inform the development of new cannabis-based treatments. The growth in the number of clinical trials is also driving the demand for high-quality cannabis products that meet the standards required for use in clinical studies.
For instance; on January 17th, 2022; Bod Australia, a medicinal cannabis company, received clinical trial authorization from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to conduct a trial of its cannabis-based product, MediCabilis 5%, to treat long Covid-19. The trial will investigate the potential of MediCabilis 5% to alleviate symptoms associated with long Covid-19, such as fatigue, brain fog, and respiratory problems.
Moreover, rising number of technological advancements are also fostering the market growth. The advancements in testing technologies are leading to the development of new and improved testing methods for cannabis products. This is driving the demand for cannabis testing services to ensure that products are tested using the latest technologies and techniques.
However, the high startup cost of cannabis testing laboratories is expected to hinder the market growth. In spite of that, development of standardized testing methods may provide more opportunities for the further growth of global cannabis testing market.
North America is expected to dominate the global cannabis testing market due to rigorous guidelines, presence of major market players and favorable legislation in this region. The rigorous guidelines set by the government for marijuana cultivators have led to an increase in the number of testing laboratories in North America.
For instance; the US Food and Drug Administration (FDA) has finalized a guidance document for conducting clinical research on cannabis-derived products. The guidance is aimed at helping sponsors and investigators navigate the regulatory requirements for conducting clinical trials on drugs containing cannabis or cannabis-derived compounds. This has helped to ensure the safety and quality of cannabis products, which is critical to the growth of the cannabis market.
In addition, North America is home to a large number of cannabis cultivators, particularly in the United States and Canada. The presence of a large number of cultivators in the region has led to an increase in demand for testing services, which is driving the growth of the cannabis testing market. For instance; Thermo Fischer Inc., Digi path Inc, Step Hill Inc., SC Laboratories Inc., and Pharm labs LLC.
Moreover, the legalization of cannabis for medical and/or recreational use in several states in the U.S. and across Canada has been a significant driver of the cannabis market's growth in North America. The easing of regulations has opened up new markets, creating new opportunities for cannabis producers, retailers, and investors, which is driving the demand for testing services.
The European market for cannabis testing services is expected to experience significant growth due to the increasing legalization of cannabis and the rising usage of cannabis in drug development and research in this region. As more countries legalize medical cannabis, the demand for testing services is likely to increase, as regulators seek to ensure that cannabis products are safe and of high quality.
In addition, another factor driving the growth of the cannabis testing market in Europe is the rising usage of cannabis in drug development and research. For instance; as per the news published on February 16th, 2023; Oxford planned to study trial cannabis-based medicine as treatment for psychosis, in which the Oxford scientists will investigate whether cannabis-based medicine can treat people with psychosis or psychotic symptoms. Hence, as more research is conducted on the medical potential of cannabis, the demand for testing services is likely to increase.
Moreover, the market for cannabis products is strictly regulated in Europe, with most countries banning products containing more than 0.3% THC. This has created a need for accurate and reliable testing services to ensure that products are in compliance with these regulations. As the cannabis industry in Europe continues to mature, the demand for testing services is expected to grow rapidly.
Green Scientific Labs Launched a New, Proprietary Laboratory Information
On July 25th, 2022; A new laboratory information management system (LIMS) for immediate use across all its laboratory operations launched by Green Scientific Labs Holdings Inc. leading multi-state provider of innovative cannabis and hemp testing technologies and methods. The new laboratory information management system (LIMS) with features such as artificial intelligence and real-time tracking. The company's proprietary LIMS technology contains a vigorous set of leading-edge features including Artificial Intelligence to ensure to identify bottlenecks and to ensure industry-leading testing times, digital batch downloading, and real time audit logs that compile a record of events and changes within the software.
|2016 - 2021
|2022 - 2029
|Market Size in 2022:
|USD 1402.3 Million
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2029:
|USD 3061.5 Million
|Tables, Charts & Figures:
|Agilent Technologies, Thermo Fisher Scientific, Inc., Shimadzu Corporation, PerkinElmer, Inc., Waters Corporation, CannaSafe Analytics, Steep Hill Labs, SC Laboratories, EVIO Labs, Anresco Laboratories and others
|By Product & Software, By Test Type, By End Users
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®